September 13th 2024
The authors urge that screening, prevention, and treatment of anxiety and depression should be important health care priorities for youth who have chronic pain.
Multiple Sclerosis Therapy for Pediatric Patients Approved by FDA
May 12th 2018Officials with the FDA have approved fingolimod (Gilenya, Novartis) for the treatment of relapsing multiple sclerosis in pediatric patients aged 10 years and older, making it the first FDA-approved drug to treat MS in this population.
Read More
ACIP Releases Revised 2018 Child and Adolescent Vaccine Schedule
February 7th 2018The updated 2018 immunization schedules for children and teens has been released by the Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) and the American Academy of Pediatrics (AAP).
Read More